NanoVibronix Ownership
| NAOV Stock | USD 3.26 0.19 6.19% |
Shares in Circulation | First Issued 2012-09-30 | Previous Quarter 2.8 M | Current Value 2.8 M | Avarage Shares Outstanding 2 M | Quarterly Volatility 5 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
NanoVibronix |
NanoVibronix Stock Ownership Analysis
The company has price-to-book ratio of 1.46. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. NanoVibronix recorded a loss per share of 13.53. The entity had not issued any dividends in recent years. The firm had 1:11 split on the 14th of March 2025. NanoVibronix, Inc., through its subsidiary, NanoVibronix Ltd., focuses on the manufacture and sale of noninvasive biological response-activating devices that target biofilm prevention, wound healing, and pain therapy. NanoVibronix, Inc. was incorporated in 2003 and is based in Elmsford, New York. Nanovibronix operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 12 people. To find out more about NanoVibronix contact Brian Murphy at 914 233 3004 or learn more at https://www.nanovibronix.com.Besides selling stocks to institutional investors, NanoVibronix also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different NanoVibronix's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align NanoVibronix's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
NanoVibronix Quarterly Liabilities And Stockholders Equity |
|
NanoVibronix Insider Trades History
Less than 1% of NanoVibronix are currently held by insiders. Unlike NanoVibronix's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against NanoVibronix's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of NanoVibronix's insider trades
NanoVibronix Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as NanoVibronix is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading NanoVibronix backward and forwards among themselves. NanoVibronix's institutional investor refers to the entity that pools money to purchase NanoVibronix's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Armistice Capital, Llc | 2024-12-31 | 189.3 K | Citadel Advisors Llc | 2024-12-31 | 43.6 K | Ubs Group Ag | 2024-12-31 | 41.2 K | Vanguard Group Inc | 2024-12-31 | 30.2 K | Geode Capital Management, Llc | 2024-12-31 | 22.5 K | Virtu Financial Llc | 2024-12-31 | 19.4 K | Two Sigma Securities, Llc | 2024-12-31 | 11 K | Tower Research Capital Llc | 2024-12-31 | 6 K | Bank Of America Corp | 2024-12-31 | 32.0 | Renaissance Technologies Corp | 2024-12-31 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 |
NanoVibronix Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific NanoVibronix insiders, such as employees or executives, is commonly permitted as long as it does not rely on NanoVibronix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases NanoVibronix insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
NanoVibronix Outstanding Bonds
NanoVibronix issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NanoVibronix uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NanoVibronix bonds can be classified according to their maturity, which is the date when NanoVibronix has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
NanoVibronix Corporate Filings
8K | 14th of March 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 27th of January 2025 Other Reports | ViewVerify | |
| 16th of January 2025 Other Reports | ViewVerify | |
F4 | 3rd of January 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for NanoVibronix Stock Analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.